Ionis Pharmaceuticals (IONS) Share-based Compensation (2011 - 2026)
Ionis Pharmaceuticals (IONS) posted quarterly Share-based Compensation of $20.3 million for Q2 2026, up 1475.27% year-over-year from $1.3 million in Q2 2025, and down 64.65% quarter-over-quarter from $57.3 million in Q1 2026.
Ionis Pharmaceuticals (IONS) Share-based Compensation (2011 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Share-based Compensation history runs 16 years deep, the most recent figure standing at $20.3 million for Q2 2026.
- In Q2 2026, Share-based Compensation rose 1475.27% year-over-year to $20.3 million; the TTM figure through Jun 2026 stood at $260.9 million (up 251.79% YoY), while the FY2025 annual figure was $192.6 million, up 47.93% from the prior year.
- Share-based Compensation for Q2 2026 stood at $20.3 million, down from $57.3 million in the prior quarter.
- The five-year high for Share-based Compensation was $102.0 million in Q4 2025, with the low at $1.3 million in Q2 2025.
- The 5-year median for Share-based Compensation is $26.4 million (2023), against an average of $34.5 million.
- The sharpest annual moves came in 2024 and 2026: Share-based Compensation tumbled 90.23% in 2024, then soared 1475.27% in 2026.
- Ionis Pharmaceuticals' Share-based Compensation stood at $94.4 million in 2022, then tumbled by 72.09% to $26.3 million in 2023, then surged by 37.26% to $36.1 million in 2024, then jumped by 182.31% to $102.0 million in 2025, then sank by 80.15% to $20.3 million in 2026.
- Business Quant data shows IONS's Share-based Compensation at $20.3 million in Q2 2026, $57.3 million in Q1 2026, and $102.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 277.20 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 137.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 590,899.88 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 86.63 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 41.25 Mn |
| 10 | Ionis Pharmaceuticals | 9.48 Bn | 7.43 Bn | 265.21 Mn | 20.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.26 Mn |
| Jun 30, 2026 | 20.26 Mn |
| Mar 31, 2026 | 57.30 Mn |
| Mar 31, 2026 | 57.30 Mn |
| Dec 31, 2025 | 102.05 Mn |
| Dec 31, 2025 | 102.05 Mn |
| Sep 30, 2025 | 81.26 Mn |
| Sep 30, 2025 | 81.26 Mn |
| Jun 30, 2025 | 1.29 Mn |
| Jun 30, 2025 | 1.29 Mn |
| Mar 31, 2025 | 29.72 Mn |
| Mar 31, 2025 | 29.72 Mn |
| Dec 31, 2024 | 36.15 Mn |
| Dec 31, 2024 | 36.15 Mn |
| Sep 30, 2024 | 7.00 Mn |
| Sep 30, 2024 | 7.00 Mn |
| Jun 30, 2024 | 2.59 Mn |
| Jun 30, 2024 | 2.59 Mn |
| Mar 31, 2024 | 31.34 Mn |
| Mar 31, 2024 | 31.34 Mn |